482 related articles for article (PubMed ID: 9617592)
1. Current drug treatment strategies for disseminated intravascular coagulation.
de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
Yamada S; Asakura H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
[TBL] [Abstract][Full Text] [Related]
5. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer-associated disseminated intravascular coagulation.
Levi M
Thromb Res; 2016 Apr; 140 Suppl 1():S66-70. PubMed ID: 27067981
[TBL] [Abstract][Full Text] [Related]
7. Plasma and plasma components in the management of disseminated intravascular coagulation.
Levi M; de Jonge E; van der Poll T
Best Pract Res Clin Haematol; 2006; 19(1):127-42. PubMed ID: 16377546
[TBL] [Abstract][Full Text] [Related]
8. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.
Levi M; de Jonge E; van der Poll T
Ann Med; 2004; 36(1):41-9. PubMed ID: 15000346
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to the management of disseminated intravascular coagulation.
Levi M; de Jonge E; van der Poll T; ten Cate H
Crit Care Med; 2000 Sep; 28(9 Suppl):S20-4. PubMed ID: 11007192
[TBL] [Abstract][Full Text] [Related]
10. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.
Levi M; de Jonge E; van der Poll T; ten Cate H
Semin Thromb Hemost; 2001 Dec; 27(6):569-75. PubMed ID: 11740680
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of DIC associated with myelogenous leukemia].
Sakata Y
Nihon Rinsho; 2009 Oct; 67(10):1978-83. PubMed ID: 19860201
[TBL] [Abstract][Full Text] [Related]
12. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
13. Expert consensus for the treatment of disseminated intravascular coagulation in Japan.
Wada H; Asakura H; Okamoto K; Iba T; Uchiyama T; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S; Kushimoto S; Seki Y; Madoiwa S; Maruyama I; Yoshioka A;
Thromb Res; 2010 Jan; 125(1):6-11. PubMed ID: 19782389
[TBL] [Abstract][Full Text] [Related]
14. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.
Aoki N; Matsuda T; Saito H; Takatsuki K; Okajima K; Takahashi H; Takamatsu J; Asakura H; Ogawa N;
Int J Hematol; 2002 Jun; 75(5):540-7. PubMed ID: 12095157
[TBL] [Abstract][Full Text] [Related]
15. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
16. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
17. [Disseminated intravascular coagulation].
Levi M; de Jonge E; ten Cate H
Ned Tijdschr Geneeskd; 2000 Mar; 144(10):470-5. PubMed ID: 10726156
[TBL] [Abstract][Full Text] [Related]
18. Sepsis and disseminated intravascular coagulation.
Levi M; de Jonge E; van der Poll T
J Thromb Thrombolysis; 2003; 16(1-2):43-7. PubMed ID: 14760211
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
20. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
